Table 3. Differences in clinical parameters among patients with WS with or without diabetes.
| Without diabetes | n | Diabetes | n | p value | |
|---|---|---|---|---|---|
| Age (year) | 44±6.9 | 5 | 53±9.1 | 4 | 0.16 |
| 25-question GLFS score | 40±31.7 | 4 | 43±18.8 | 4 | 0.88 |
| Two-step test value | 0.73±0.49 | 5 | 0.60±0.51 | 4 | 0.71 |
| Grip strength (kg) | 20.1±7.1 | 5 | 12.5±5.1 | 4 | 0.11 |
| VFA (cm2) | 56.1±43.6 | 4 | 142.6±40.1 | 3 | 0.04* |
| SMI (kg/m2) | 4.2±0.7 | 5 | 3.8±0.4 | 3 | 0.4 |
| BMD (L) (YAM) | 89.4±13.8 | 5 | 83.3±8.4 | 3 | 0.47 |
| BMD (F) (YAM) | 75.3±4.6 | 4 | 61.7±5.7 | 3 | 0.03* |
| BW (kg) | 40.4±7.5 | 5 | 42.9±6.6 | 4 | 0.61 |
| BMI (kg/m2) | 16.2±1.2 | 5 | 18.7±1.3 | 4 | 0.02* |
| Adiponectin (ng/mL) | 6.4±2.8 | 4 | 6.6±4.1 | 4 | 0.95 |
| TNF-α (pg/mL) | 1.4±0.6 | 4 | 3.0±4.3 | 4 | 0.51 |
| Leptin (ng/nL) | 7.2±3.6 | 4 | 30.0±16.9 | 4 | 0.07 |
GLFS: geriatric locomotive function scale, VFA: visceral fat area, SMI: skeletal muscle index, BMD (L): bone mineral density (lumbar spine), BMD (F): bone mineral density (femoral neck), YAM: young adult mean, BW: body weight BMI: body mass index, TNF: tumor necrosis factor, * p <0.05